Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Alberta

$35,000.00

Engineered Macromolecular and Nanostructured Materials for Biomedical Relevance

EF 2015-16

Résumé
Gene therapy has drawn significant attention over the past two decades for the treatment of inherited and acquired diseases. Despite the considerable interest in gene therapy, delivery of genes to the target cells remains a huge challenge. Major research efforts are currently focused on designing suitable carrier vectors that compact and protect oligonucleotides for gene therapy. DNA or RNA is large, hydrophilic, negatively charged macromolecule, very unstable in the physiological environment and does not cross biological membranes effectively. Since both the genes and cell surfaces are negatively charged, spontaneous entry of unprotected genes inside cells is difficult. Research was initially focused on viruses as these vectors exhibited high efficiency at delivering both DNA and RNA to numerous cell lines. However, several problems associated with viral vector systems, such as toxicity, immunogenicity and limitations with respect to scale-up procedures encouraged the exploration of other potential DNA or RNA carriers into targeted tissue. Non-viral vector systems are other means for compacting DNA for systemic delivery, but, unlike viral analogues, non-viral gene carriers consistently demonstrate significant reduced transfection efficiency due to numerous extra- and intracellular obstacles. Their biocompatibility and facilitated production make them potentially useful and attractive for gene therapy. As carbohydrates are prominent on cell surfaces, they are involved in a number of cellular processes and modulate many cellular interactions. Therefore, it is not unreasonable to develop carbohydrate-based nano-systems for gene therapy since diligent engineering of these materials can transform them into highly innovative therapeutics. We have established the reversible addition-fragmentation chain transfer process (RAFT) for designing well-defined polymers mainly based on the ease of synthesizing water-soluble polymers. The RAFT process has enabled us to design and fabricate advanced cationic glycopolymers and nanogels with low toxicity for DNA/siRNA delivery. This remarkable control on the design of biomaterials has had significant impact on both their physicochemical and biological properties. Our motivation in this research program is towards the evaluation of novel carbohydrate-based macro/nano-structures for the delivery of genes in vitro. Those carbohydrate vector systems will be essentially galactose based polymers and nanogels with biologically relevant motifs for targeted and safe delivery.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2015-06339
Name nom
Narain, Ravin
Department département
Chemical and Materials Engineering - Chemical and Materials Engineering
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
35000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
3754
Research subject group en
Polymer chemistry
Research subject group fr
Chimie des polymères
Research subject en
Biopolymers
Research subject fr
Biopolymères
Partie
1
Nb partie
5
Application title
Engineered Macromolecular and Nanostructured Materials for Biomedical Relevance
Keyword
NSERC
Application summary
<p>Gene therapy has drawn significant attention over the past two decades for the treatment of inherited and acquired diseases. Despite the considerable interest in gene therapy, delivery of genes to the target cells remains a huge challenge. Major research efforts are currently focused on designing suitable carrier vectors that compact and protect oligonucleotides for gene therapy. DNA or RNA is large, hydrophilic, negatively charged macromolecule, very unstable in the physiological environment and does not cross biological membranes effectively. Since both the genes and cell surfaces are negatively charged, spontaneous entry of unprotected genes inside cells is difficult. Research was initially focused on viruses as these vectors exhibited high efficiency at delivering both DNA and RNA to numerous cell lines. However, several problems associated with viral vector systems, such as toxicity, immunogenicity and limitations with respect to scale-up procedures encouraged the exploration of other potential DNA or RNA carriers into targeted tissue. Non-viral vector systems are other means for compacting DNA for systemic delivery, but, unlike viral analogues, non-viral gene carriers consistently demonstrate significant reduced transfection efficiency due to numerous extra- and intracellular obstacles. Their biocompatibility and facilitated production make them potentially useful and attractive for gene therapy. As carbohydrates are prominent on cell surfaces, they are involved in a number of cellular processes and modulate many cellular interactions. Therefore, it is not unreasonable to develop carbohydrate-based nano-systems for gene therapy since diligent engineering of these materials can transform them into highly innovative therapeutics. We have established the reversible addition-fragmentation chain transfer process (RAFT) for designing well-defined polymers mainly based on the ease of synthesizing water-soluble polymers. The RAFT process has enabled us to design and fabricate advanced cationic glycopolymers and nanogels with low toxicity for DNA/siRNA delivery. This remarkable control on the design of biomaterials has had significant impact on both their physicochemical and biological properties. Our motivation in this research program is towards the evaluation of novel carbohydrate-based macro/nano-structures for the delivery of genes in vitro. Those carbohydrate vector systems will be essentially galactose based polymers and nanogels with biologically relevant motifs for targeted and safe delivery.</p>